GGrantIndex
← Leaderboards

David W Roberts

Insight Surgical Technologies Inc.

$12,304,549
Attributed
$13,743,388
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,743,388 · 7

By mechanism

R01$7,486,515 · 2
R44$5,796,953 · 3
R43$459,920 · 2

Top collaborators

Others in their field

Top investigators on “Excision

Research focus

ExcisionDesignOperative Surgical ProceduresGliomaImageFluorescenceTumorTechnologyMagnetic Resonance ImagingSurgeonBrain NeoplasmsBaseBrain Tumor ResectionEvaluationFluorescence ImagingTissuesFluorophoreMicroscopeSurfaceOpticsPerformanceDetectionProceduresInstrument

Grant awards (26)

Optical Analogs to MRI Contrast Agents for Surgical Guidance of Brain Tumor Resection$498,649
R01 · FY2025 · NS
Intraoperative Stereovision for Surgical Guidance$899,697
R44 · FY2024 · CA · contact PI
Optical Analogs to MRI Contrast Agents for Surgical Guidance of Brain Tumor Resection$569,091
R01 · FY2024 · NS
Wide-Field Quantitative Fluorescence Imaging System$589,765
R44 · FY2023 · CA · contact PI
Optical Analogs to MRI Contrast Agents for Surgical Guidance of Brain Tumor Resection$577,052
R01 · FY2023 · NS
Wide-Field Quantitative Fluorescence Imaging System$1,012,560
R44 · FY2022 · CA · contact PI
Intraoperative Stereovision for Surgical Guidance$914,712
R44 · FY2022 · CA · contact PI
Optical analogs to MRI contrast agents for surgical guidance of brain tumor resection$609,036
R01 · FY2022 · NS
Probe for Quantitative Fluorescence. Phase 2$1,080,934
R44 · FY2021 · NS · contact PI
Optical analogs to MRI contrast agents for surgical guidance of brain tumor resection$623,851
R01 · FY2021 · NS
Wide-Field Quantitative Fluorescence Imaging System$210,861
R44 · FY2021 · CA · contact PI
Probe for Quantitative Fluorescence. Phase 2$1,088,424
R44 · FY2020 · NS · contact PI
Intraoperative Stereovision for Surgical Guidance$236,059
R43 · FY2019 · CA · contact PI
Coregistered Fluorescence-Enhanced Resection of Malignant Glioma$467,450
R01 · FY2018 · NS · contact PI
Probe for Quantitative Fluorescence$223,861
R43 · FY2018 · NS · contact PI
Coregistered Fluorescence-Enhanced Resection of Malignant Glioma$41,800
R01 · FY2018 · NS · contact PI
Coregistered Fluorescence-Enhanced Resection of Malignant Glioma$511,847
R01 · FY2017 · NS · contact PI
Coregistered Fluorescence-Enhanced Resection of Malignant Glioma$496,287
R01 · FY2016 · NS · contact PI
Coregistered Fluorescence-Enhanced Resection of Malignant Glioma$521,913
R01 · FY2015 · NS · contact PI
Coregistered Fluorescence-Enhanced Resection of Malignant Glioma$539,495
R01 · FY2014 · NS · contact PI
Coregistered Fluorescence-Enhanced Resection of Malignant Glioma$348,259
R01 · FY2011 · NS · contact PI
Coregistered Fluorescence-Enhanced Resection of Malignant Glioma$342,146
R01 · FY2010 · NS · contact PI
Coregistered Fluorescence-Enhanced Resection of Malignant Glioma$409,662
R01 · FY2009 · NS · contact PI
Coregistered Fluorescence-Enhanced Resection of Malignant Glioma$79,000
R01 · FY2009 · NS · contact PI
Coregistered Fluorescence-Enhanced Resection of Malignant Glioma$400,936
R01 · FY2008 · NS · contact PI
Coregistered Fluorescence-Enhanced Resection of Malignant Glioma$450,041
R01 · FY2007 · NS · contact PI